University of Ioannina
Η επίδραση χαμηλών δόσεων αναστολέων της φωσφοδιεστεράσης 5 σε ποιοτικές και ποσοτικές παραμέτρους του σπέρματος
Abstract
dc:descriptionThe purpose of this clinical thesis was to study the effect of low doses of phosphodiesterase 5 inhibitors (sildenafil and vardenafil) on the quantitative and qualitative parameters of sperm and reproductive hormones in infertile male. The research protocol was based on a total of 110 infertile men divided into 4 groups. The 22 men in Group A (n = 22) were administered sildenafil 12.5 mg daily for 30 days. Group B comprising of 22 infertile men (n = 22) was given daily sildenafil 12.5mg for 60 days. Group C included another 22 patients (n = 22) who were receiving vardenafil 5mg daily for 30 days. The 22 patients selected for group D (n = 22) were administered vardenafil 5mg daily for 60 days. Finally, group E included another 22 infertile men (n = 22) who formed the control group without receiving any medication for the 60-day follow-up. All men from each group underwent sperm testing and hormone testing before the study and 48 hours after the last dose of the drug. Sperm volume (ml), sperm concentration (x106/ml), percentage of motile spermatozoa at 1 hour (MS%), and percentage morphologically normal sperm (MNS%) were determined in each sperm sample. All of the infertile men included in the study were subjected to hormone testing that included total testosterone - T. Testo (ng/ml), prolactin - PRL (ng/ml), estradiol - E2 (pg/ml), follicle stimulating hormone - FSH (IU/ml) and luteinizing hormone - LH (IU/ml) on the peripheral blood serum. Finally, the testosterone / estradiol ratio was also calculated. The analysis of the results of this study shows that sildenafil administration increases sperm motility while the percentage of morphologically normal spermatozoa and the ratio of total testosterone to estradiol increase statistically significantly after treatment with either sildenafil or vardenafil. The positive effect of selective inhibitors of PDE5 in motility and morphology of sperm makes us hope in the integration of these drugs into the urologist's therapeutic pharmaceutical options for treating male infertility. Also, the increase in the ratio of total testosterone to estradiol observed in men of the study, which may be expressed as an inhibitory effect of these drugs on aromatase function, in combination with the fact that PDE5 is overexpressed in various cancerous tissues opens new horizons in research for the possible use of PDE5i as antineoplastic drugs. Further studies are undoubtedly needed to clarify whether in the future PDE selective inhibitors will be used as an auxiliary tool in the treatment of male infertility.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koukos, Sotirios
- Κούκος, Σωτήριος
Subjects
dc:subject × 20- Αναστολείς φωσφοδιεστεράσης 5
- Σιλδεναφίλη
- Βαρδεναφίλη
- Παράμετροι σπέρματος
- Σπερματοζωάρια
- Όρχις
- Ανδρική υπογονιμότητα
- Phosphodiesterase 5 inhibitors
- Sildenafil
- Vardenafil
- Semen parameters
- Spermatozoa
- Testis
- Male infertility
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48202